• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸盐转运体软骨发育不全中源自巯基化合物的体外蛋白聚糖硫酸化作用

In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.

作者信息

Rossi Antonio, Cetta Giuseppe, Piazza Rocco, Bonaventure Jacky, Steinmann Beat, Supereti-Furga Andrea

机构信息

Dipartimento di Biochimica Alessandro Castellani, Università di Pavia, Pavia, Italy.

出版信息

Pediatr Pathol Mol Med. 2003 Jul-Aug;22(4):311-21. doi: 10.1080/pdp.22.4.311.321.

DOI:10.1080/pdp.22.4.311.321
PMID:14692227
Abstract

Mutations in a sulfate-chloride antiporter gene, the diastrophic dysplasia sulfate transporter (DTDST), have been associated with a family of skeletal dysplasias including recessive multiple epiphyseal dysplasia, diastrophic dysplasia (DTD), atelosteogenesis type 2, and achondrogenesis type 1B (ACG1B). DTDST function is crucial for uptake of extracellular sulfate required for proteoglycan (PG) sulfation; the tissue-specific expression of the clinical phenotype may be the consequence of the high rate of PG synthesis in chondrocytes and the ensuing high sulfate requirement. We have studied the contribution of cysteine and its derivatives to PG sulfation in fibroblast and chondrocyte cultures from sulfate transporter dysplasia patients. Incubation of ACG1B fibroblasts in medium containing different concentrations of cystine indicated partial recovery of PG sulfation as measured by HPLC disaccharide analysis of chondroitin sulfate PGs; similar results were observed after incubation with N-acetylcysteine. When both compounds were tested in primary chondrocytes from a DTD patient, partial rescue of PG sulfation was observed, suggesting that the metabolic pathways producing cytoplasmic sulfate from thiols are also active in this cell type.

摘要

硫酸盐 - 氯离子反向转运体基因——脊柱骨骺发育不良硫酸盐转运体(DTDST)发生突变,与一系列骨骼发育不良相关,包括隐性多发性骨骺发育不良、脊柱骨骺发育不良(DTD)、2型atelosteogenesis和1B型软骨发育不全(ACG1B)。DTDST功能对于蛋白聚糖(PG)硫酸化所需的细胞外硫酸盐摄取至关重要;临床表型的组织特异性表达可能是软骨细胞中PG合成率高以及随之而来的高硫酸盐需求的结果。我们研究了半胱氨酸及其衍生物对硫酸盐转运体发育不良患者成纤维细胞和软骨细胞培养物中PG硫酸化的作用。通过硫酸软骨素PG的HPLC二糖分析测定,将ACG1B成纤维细胞在含有不同浓度胱氨酸的培养基中孵育表明PG硫酸化有部分恢复;用N - 乙酰半胱氨酸孵育后也观察到类似结果。当在一名DTD患者的原代软骨细胞中测试这两种化合物时,观察到PG硫酸化有部分挽救,表明从硫醇产生细胞质硫酸盐的代谢途径在这种细胞类型中也有活性。

相似文献

1
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.硫酸盐转运体软骨发育不全中源自巯基化合物的体外蛋白聚糖硫酸化作用
Pediatr Pathol Mol Med. 2003 Jul-Aug;22(4):311-21. doi: 10.1080/pdp.22.4.311.321.
2
Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.在麦卡利斯特发育异常/2型atelosteogenesis中,软骨蛋白聚糖在体外硫酸化不足,且体外氨基酸硫对硫酸化的贡献增加。
Eur J Biochem. 1997 Sep 15;248(3):741-7. doi: 10.1111/j.1432-1033.1997.t01-1-00741.x.
3
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.硫酸盐转运体软骨发育不全患者软骨及细胞培养物中的蛋白聚糖硫酸化:与临床严重程度的关系及细胞内硫酸盐产生作用的指征
Matrix Biol. 1998 Oct;17(5):361-9. doi: 10.1016/s0945-053x(98)90088-9.
4
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.来自一名1B型软骨发育不全患者的软骨细胞合成的蛋白聚糖硫酸化不足,该患者为双等位基因L483P替代的硫酸软骨素转运体双等位基因突变纯合子。
J Biol Chem. 1996 Aug 2;271(31):18456-64. doi: 10.1074/jbc.271.31.18456.
5
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation.氨基酸硫对软骨蛋白聚糖硫酸化的体内作用。
Biochem J. 2006 Sep 15;398(3):509-14. doi: 10.1042/BJ20060566.
6
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.脊柱骨骺发育不良硫酸盐转运体(DTDST)基因突变:硫酸盐转运活性与软骨发育不良表型之间的相关性。
Hum Mol Genet. 2001 Jul 1;10(14):1485-90. doi: 10.1093/hmg/10.14.1485.
7
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.一种脊柱胸腰段发育不良性硫酸酯转运体(SLC26A2)突变小鼠:所产生的软骨发育不良表型的形态学和生物化学特征
Hum Mol Genet. 2005 Mar 15;14(6):859-71. doi: 10.1093/hmg/ddi079. Epub 2005 Feb 9.
8
Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.II型atelosteogenesis由硫酸软骨发育不全转运体基因(DTDST)突变引起:涉及三种软骨发育不良的表型系列证据。
Am J Hum Genet. 1996 Feb;58(2):255-62.
9
Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.2型肢体骨发育不全与脊柱发育不良之间的表型和基因型重叠。
Hum Genet. 1996 Dec;98(6):657-61. doi: 10.1007/s004390050279.
10
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.脊柱骨骺发育不良硫酸盐转运体(DTDST)基因(SLC26A2)的突变:22种新突变、突变综述、相关骨骼表型及诊断意义
Hum Mutat. 2001 Mar;17(3):159-71. doi: 10.1002/humu.1.

引用本文的文献

1
Biallelic variants in the SLC13A1 sulfate transporter gene cause hyposulfatemia with a mild spondylo-epi-metaphyseal dysplasia.SLC13A1 硫酸盐转运基因的双等位基因突变可导致低硫酸血症伴轻度脊椎-骨骺-干骺端发育不良。
Clin Genet. 2023 Jan;103(1):45-52. doi: 10.1111/cge.14239. Epub 2022 Oct 3.
2
Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain.溶质载体家族26成员9(Slc26a9)通过STAS结构域被囊性纤维化跨膜传导调节因子的R区域所抑制。
J Biol Chem. 2009 Oct 9;284(41):28306-28318. doi: 10.1074/jbc.M109.001669. Epub 2009 Jul 30.
3
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation.氨基酸硫对软骨蛋白聚糖硫酸化的体内作用。
Biochem J. 2006 Sep 15;398(3):509-14. doi: 10.1042/BJ20060566.